Michael H. Tomasson
Affiliations: | Biology & Biomedical Sciences (Molecular Cell Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Genetics, OncologyGoogle:
"Michael Tomasson"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gao M, Bai H, Jethava Y, et al. (2019) Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. Journal of the National Cancer Institute |
| Ali M, Kowkuntla S, Delloro DJ, et al. (2019) Chronic intermittent hypoxia enhances disease progression in myeloma-resistant mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology |
| Glenn MJ, Madsen MJ, Davis E, et al. (2019) Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees. Blood Cancer Journal. 9: 25 |
| Nadiminti K, Strouse C, Sidiqi MH, et al. (2019) Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) Biology of Blood and Marrow Transplantation. 25: S399-S400 |
| White BS, Lanc I, O'Neal J, et al. (2018) A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer Journal. 8: 35 |
| Kotagiri N, Cooper ML, Rettig M, et al. (2018) Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nature Communications. 9: 275 |
| Nadiminti K, Strouse C, Vikas P, et al. (2018) A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783) Blood. 132: 2153-2153 |
| Nadiminti K, Strouse C, Vikas P, et al. (2018) Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience Blood. 132: 2152-2152 |
| Du Z, Song C, Rand K, et al. (2018) Abstract 223: A meta-analysis of genome-wide association studies of multiple myeloma among African Americans Cancer Research. 78: 223-223 |
| Mahajan N, Wu HJ, Bennett RL, et al. (2017) Sabotaging of the oxidative stress response by an oncogenic noncoding RNA. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 31: 482-490 |